Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №6 (2024) > Blueberry polyphenols for prevention of urinary tract infection: future perspectives

Blueberry polyphenols for prevention of urinary tract infection: future perspectives

Anton I. Maliavin , Lev E. Belyi

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Prophylactic administration of antibiotics for urinary tract infections should be the last resort after all other preventive measures have been exhausted. This is due to the resistance of microbial flora to antibiotics, a lot of side effects of antibiotic therapy. Non-antimicrobial prevention should include the elimination of possible risk factors, behavioral modifications, as well as various options for non-antimicrobial prevention. An anti-adhesive strategy is being actively developed when various chemicals prevent the adhesion of bacteria to the urothelium. One of the variants of this strategy is the use of cranberries. Cranberries contain polyphenols with anti-adhesive potential. Other plants, representatives of the genus Vaccinium, may also be of practical interest. Blueberries are widely used in the food and pharmaceutical industries, which requires studying their phytochemical composition and anti-adhesive capabilities. Today, a significant number of in vitro studies have been conducted demonstrating both the anti-adhesive and antimicrobial potential of extracts from blueberry leaves and berries. Extracts from blueberries suppressed pathogens from urine samples, including Escherichia coli strains. Blueberry extract inhibited biofilm formation and bacterial adhesion when testing polyresistant isolates of Pseudomonas aeruginosa, E. coli, Proteus mirabilis, Acinetobacter baumannii and Staphylococcus aureus. Blueberry polyphenolic compounds inactivate E. coli and other gram-positive and gram-negative bacteria. Phytochemicals from blueberries damage the bacterial cell membrane, causing the release of protein and nucleic acids from the microbial cell, reducing the activity of some microbial enzymes. Blueberry anthocyanins can reduce the level of ATPase in the microbial cell, increasing the outflow of ATP from the cytoplasm, which has a negative effect on energy metabolism. Phytochemicals contained in blueberries can affect the transcription of genes in a microbial cell, which reduces the adaptive potential of microorganisms, and can also lead to the restoration of the sensitivity of microorganisms to certain antibiotics. There is a need for further clinical studies evaluating the effectiveness of the use of blueberries and blueberry products as an option for non-antimicrobial prevention of urinary tract infection.
Keywords: blueberries, blueberry extracts, urinary tract infection, proanthocyanidins, anthocyanins, polyphenols, uropathogenic Escherichia coli.

About the Author

Anton I. Maliavin 1 , Lev E. Belyi 2

1 City Policlinic №4, Ulyanovsk, Russia

2 Ulyanovsk State University, Ulyanovsk, Russia

References

1. Najar MS, Saldanha CL, Banday KA. Approach to urinary tract infections. Indian J Nephrol 2009;19(4):129-39. DOI: 10.4103/0971-4065.59333
2. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan, Italy 2023.
3. Рафальский В.В., Моисеева Е.М. Эпидемиология неосложненных внебольничных инфекций мочевыводящих путей в Российской Федерации. Вестник урологии. 2018;6(2):30-7. DOI: 10.21886/ 2308-6424-2018-6-2-30-37
Rafalsky V.V., Moiseeva E.M. Epidemiology of uncomplicated outpatient urinary tract infections in the Russian Federation. Urology Herald. 2018;6(2):30-7. DOI: 10.21886/2308-6424-2018-6-2-30-37 (in Russian).
4. Haylen BT, Lee J, Husselbee S et al. Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(7):837-42. DOI: 10.1007/s00192-009-0856-3
5. Nicolosi D, Tempera G, Genovese C, Furneri PM. Anti-adhesion activity of A2-type proanthocyanidins (a cranberry major component) on uropathogenic E. coli and P. mirabilis strains. Antibiotics (Basel) 2014;3(2):143-54. DOI: 10.3390/antibiotics3020143
6. Beerepoot M, Geerlings S. Non-antibiotic prophylaxis for urinary tract infections. Pathogens. 2016;5(2):36. DOI: 10.3390/pathogens5020036
7. Schaeffer AJ, Jones JM, Dunn JK. Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N Engl J Med 1981;304(18):1062-6. DOI: 10.1056/NEJM198104303041802
8. Scholes D, Hawn TR, Roberts PL et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol 2010;184(2):564-9. DOI: 10.1016/j.juro.2010.03.139
9. Перепанова Т.С., Волкова Е.М. К вопросу патогенеза рецидивирующей инфекции нижних мочевыводящих путей. Экспериментальная и клиническая урология. 2015;(3):100-5.
Perepanova T.S., Volkova E.M. Apropos of pathogenesis of recurrent lower urinary tract infections. Eksperimentalnaya i klinicheskaya urologiya = Experimental and Clinical Urology. 2015;(3):100-5 (in Russian).
10. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001;69(7):4572-9. DOI: 10.1128/IAI.69.7.4572-4579.2001
11. Justice SS, Hung C, Theriot JA et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 2004;101(5):1333-8. DOI: 10.1073/ pnas.0308125100
12. Rosen DA, Hooton TM, Stamm WE et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007;4(12):e329. DOI: 10.1371/journal.pmed.0040329
13. Lenger SM, Bradley MS, Thomas DA et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol 2020;223(2):265.e1-265.e13. DOI: 10.1016/j.ajog.2020.05.048
14. Betschart C, Albrich WC, Brandner S et al. Guideline of the Swiss Society of Gynaecology and Obstetrics (SSGO) on acute and recurrent urinary tract infections in women, including pregnancy. Swiss Med Wkly 2020;150:w20236. DOI: 10.4414/smw.2020.20236
15. Kranz J, Schmidt S, Lebert C et al. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part 1. Urol Int 2018;100(3):263-70. DOI: 10.1159/000486138
16. Цистит у женщин. Клинические рекомендации. Режим доступа: https://cr.minzdrav.gov.ru/recomend/14_2
Cystitis in women. Clinical recommendations. Available at: https://cr.minzdrav.gov.ru/recomend/14_2 (in Russian).
17. De Nunzio C, Bartoletti R, Tubaro A et al. Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives. Antibiotics (Basel) 2021;10(4):373. DOI: 10.3390/antibiotics10040373
18. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. 2020.
Perepanova T.S., Kozlov R.S., Rudnov V.A., Sinyakova L.A. Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs. Federal clinical guidelines. 2020 (in Russian).
19. Белый Л.Е. Перспективы применения D-маннозы в профилактике и лечении инфекции мочевых путей у женщин. Акушерство и гинекология. 2023;(5):21-8. DOI: 10.18565/aig.2022.295
Belyi L.E. Prospects for using D-mannose in the prevention and treatment of urinary tract infection in women. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2023;(5):21-8. DOI: 10.18565/aig. 2022.295 (in Russian).
20. Захарова И.Н., Османов И.М., Касьянова А.Н. и др. Протективные факторы слизистой оболочки мочевого пузыря – ключ к новым подходам к терапии инфекции мочевых путей. Российский вестник перинатологии и педиатрии. 2018;63(2):16-21. DOI: 10.21508/1027-4065-2018-63-2-16-21
Zakharova I.N., Osmanov I.M., Kasyanova A.N. et al. Protective factors of the urinary bladder mucous membrane – the key to new approaches of urinary tract infection therapy. Rossiyskiy vestnik perinatologii i pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2018;63:(2): 16–21. DOI: 10.21508/1027-4065-2018-63-2-16-21 (in Russian).
21. Lilly JD, Parsons CL. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet. 1990;171(6):493-6.
22. Schnaar RL. Glycobiology simplified: diverse roles of glycan recognition in inflammation. J Leukoc Biol 2016;99(6):825-38. DOI: 10.1189/jlb.3RI0116-021R
23. Ala-Jaakkola R, Laitila A, Ouwehand AC, Lehtoranta L. Role of D-mannose in urinary tract infections – a narrative review. Nutr J 2022;21(1): 18. DOI: 10.1186/s12937-022-00769-x
24. Pappas E, Schaich KM. Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr 2009;49(9):741-81. DOI: 10.1080/ 1040839080214537
25. González de Llano D, Liu H et al. Some New Findings Regarding the antiadhesive activity of cranberry phenolic compounds and their microbial-derived metabolites against uropathogenic bacteria. J Agric Food Chem 2019;67(8):2166-74. DOI: 10.1021/acs.jafc.8b05625
26. Feliciano RP, Boeres A, Massacessi L et al. Identification and quantification of novel cranberry-derived plasma and urinary (poly)phenols. Arch Biochem Biophys 2016;599:31-41. DOI: 10.1016/j.abb. 2016.01.014
27. Peron G, Pellizzaro A, Brun P et al. Antiadhesive Activity and Metabolomics Analysis of Rat Urine after Cranberry (Vaccinium macrocarpon Aiton) Administration. J Agric Food Chem 2017;65 (28):5657-67. DOI: 10.1021/acs.jafc.7b01856
28. Liu H, Howell AB, Zhang DJ, Khoo C. A randomized, double-blind, placebo-controlled pilot study to assess bacterial anti-adhesive activity in human urine following consumption of a cranberry supplement. Food Funct 2019;10(12):7645-52. DOI: 10.1039/c9fo01198f
29. Di Martino P, Agniel R, David K et al. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol 2006;24(1):21-7. DOI: 10.1007/s00345-005-0045-z
30. Fu Z, Liska D, Talan D, Chung M. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J Nutr 2017;147(12):2282-8. DOI: 10.3945/jn.117.254961
31. Tambunan MP, Rahardjo HE. Cranberries for women with recurrent urinary tract infection: A meta-analysis. Med J Indonesia 2019;(28):268. DOI: 0.13181/mji.v28i3.3299
32. Xia JY, Yang C, Xu DF et al. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis. PLoS One 2021;16(9):e0256992. DOI: 10.1371/journal.pone.0256992
33. Nemzer BV, Al-Taher F, Yashin A et al. Cranberry: Chemical Composition, Antioxidant Activity and Impact on Human Health: Overview. Molecules 2022;27(5):1503. DOI: 10.3390/molecules27051503
34. Fellers CR. Nutritive Value of Cranberries. Am J Public Health Nations Health 1933;23(1):13-8. DOI: 10.2105/ajph.23.1.13
35. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008;(1):CD001321. DOI: 10.1002/14651858.CD001321.pub4
36. McLeod DC, Nahata MC. Methenamine therapy and urine acidification with ascorbic acid and cranberry juice. Am J Hosp Pharm 1978;35(6):654.
37. Martău GA, Bernadette-Emőke T, Odocheanu R et al. Vaccinium Species (Ericaceae): Phytochemistry and Biological Properties of Medicinal Plants. Molecules 2023;28(4):1533. DOI: 10.3390/molecules28041533
38. Дубкова Н.З., Тухбиева Э.Х. Технология получения порошка из ягод черники. Техника и технология пищевых производств. 2010;2(17):65-8.
Dubkova N.Z., Tuhbieva E.H. Technology of the blueberry powder production. Food Processing: Techniques and Technology. 2010;2(17):65-8 (in Russian).
39. Ofek I, Goldhar J, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Adv Exp Med Biol 1996;408:179-83. DOI: 10.1007/978-1-4613-0415-9_20
40. Old DC. Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates. J Gen Microbiol 1972;71(1):149-57. DOI: 10.1099/00221287-71-1-149
41. Jepson RG, Craig JC. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res 2007;51(6):738-45. DOI: 10.1002/mnfr.200600275
42. Cerezo AB, Cătunescu GM, González MM et al. Anthocyanins in blueberries grown in hot climate exert strong antioxidant activity and may be effective against urinary tract bacteria. Antioxidants (Basel) 2020;9(6):478. DOI: 10.3390/antiox9060478
43. Debnath SC, An D. Antioxidant properties and structured biodiversity in a diverse set of wild cranberry clones. Heliyon 2019;5(4): e01493. DOI: 10.1016/j.heliyon.2019.e01493
44. Ștefănescu BE, Călinoiu LF, Ranga F et al. Chemical Composition and Biological Activities of the Nord-West Romanian Wild Bilberry (Vaccinium myrtillus L.) and Lingonberry (Vaccinium vitis-idaea L.) Leaves. Antioxidants (Basel) 2020;9(6):495. DOI: 10.3390/antiox9060495
45. Shen X, Sun X, Xie Q et al. Antimicrobial effect of blueberry (Vaccinium corymbosum L.) extracts against the growth of Listeria monocytogenes and Salmonella enteritidis. Food Control 2014; 35(1):159-65. DOI: 10.1016/j.foodcont.2013.06.040
46. Silva S, Costa EM, Mendes M et al. Antimicrobial, antiadhesive and antibiofilm activity of an ethanolic, anthocyanin-rich blueberry extract purified by solid phase extraction. J Appl Microbiol 2016;121(3):693-703. DOI: 10.1111/jam.13215
47. Marhova M, Kaynarova E. Effect of blueberry extract on pathogenic strains Escherichia coli and Proteus mirabilis. Proceedings of the Balkan Scientific Conference of Biology in Plovdiv (Bulgaria) from 19th till 21st of May 2005 (Eds B. Gruev, M. Nikolova and A. Donev), 2005; p. 21-7.
48. Vučić DM, Petkovi MR, Rodi-Grabovac BB et al. Antibacterial and antioxidant activities of bilberry (Vaccinium myrtillus L.) in vitro. African Journal of Microbiology Research 2013;(7):5130-6. DOI: 10.5897/AJMR2013.2524
49. Schmidt BM, Howell AB, McEniry B et al. Effective separation of potent antiproliferation and antiadhesion components from wild blueberry (Vaccinium angustifolium Ait.) fruits. J Agric Food Chem 2004;52(21):6433-42. DOI: 10.1021/jf049238n
50. Pertuzatti PB, Barcia MT, Rebello LPG et al. Antimicrobial activity and differentiation of anthocyanin profiles of rabbiteye and highbush blueberries using HPLC–DAD–ESI-MSn and multivariate analysis. Journal of Functional Foods. 2016;26:506-16. DOI: 10.1016/j.jff.2016.07.026
51. Gyawali R, Ibrahim SA. Impact of plant derivatives on the growth of foodborne pathogens and the functionality of probiotics. Appl Microbiol Biotechnol 2012;95(1):29-45. DOI: 10.1007/s00253-012-4117-x
52. Lacombe A, Tadepalli S, Hwang CA, Wu VC. Phytochemicals in lowbush wild blueberry inactivate Escherichia coli O157:H7 by damaging its cell membrane. Foodborne Pathog Dis 2013;10(11):944-50. DOI: 10.1089/fpd.2013.1504
53. Sun XH, Zhou TT, Wei CH et al. Antibacterial effect and mechanism of anthocyanin rich Chinese wild blueberry extract on various foodborne pathogens. Food Control 2018;94:155-61. DOI: 10.1016/j.foodcont.2018.07.012
54. Salaheen S, Jaiswal E, Joo J et al. Bioactive extracts from berry byproducts on the pathogenicity of Salmonella typhimurium. Int J Food Microbiol 2016;237:128-35. DOI: 10.1016/j.ijfoodmicro.2016.08.027
55. Zhou TT, Wei CH, Lan WQ et al. The effect of Chinese wild blueberry fractions on the growth and membrane integrity of various foodborne pathogens. J Food Sci 2020;85(5):1513-22. DOI: 10.1111/1750-3841.15077
56. Wu VC, Qiu X, de los Reyes BG et al. Application of cranberry concentrate (Vaccinium macrocarpon) to control Escherichia coli O157:H7 in ground beef and its antimicrobial mechanism related to the downregulated slp, hdeA and cfa. Food Microbiol 2009;26(1):32-8. DOI: 10.1016/j.fm.2008.07.014
57. Sun XH, Hao LR, Xie QC et al. (2020). Antimicrobial effects and membrane damage mechanism of blueberry (Vaccinium corymbosum L.) extract against Vibrio parahaemolyticus. Food Control 2020;(111): 107020. DOI: 10.1016/j.foodcont.2019.107020
58. Salaheen S, Peng M, Joo J et al. Eradication and Sensitization of Methicillin Resistant Staphylococcus aureus to Methicillin with Bioactive Extracts of Berry Pomace. Front Microbiol 2017;8:253. DOI: 10.3389/ fmicb.2017.00253

For citation:Maliavin A.I., Belyi L.E. Blueberry polyphenols for prevention of urinary tract infection: future perspectives. Clinical review for general medicine. 2024; 5 (6): 69–75 (In russ.). doI: 10.47407/kr2024.5.6.00437


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru